These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32366671)

  • 41. Biodistribution, Tumor Detection, and Radiation Dosimetry of
    Young CR; Adler S; Eary JF; Lindenberg ML; Jacobs PM; Collins J; Kummar S; Kurdziel KA; Choyke PL; Mena E
    J Nucl Med; 2019 Apr; 60(4):492-496. PubMed ID: 30389817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preclinical Incorporation Dosimetry of [
    Sattler B; Kranz M; Wenzel B; Jain NT; Moldovan RP; Toussaint M; Deuther-Conrad W; Ludwig FA; Teodoro R; Sattler T; Sadeghzadeh M; Sabri O; Brust P
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32357571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First-in-Humans Imaging with
    Pandit-Taskar N; Postow MA; Hellmann MD; Harding JJ; Barker CA; O'Donoghue JA; Ziolkowska M; Ruan S; Lyashchenko SK; Tsai F; Farwell M; Mitchell TC; Korn R; Le W; Lewis JS; Weber WA; Behera D; Wilson I; Gordon M; Wu AM; Wolchok JD
    J Nucl Med; 2020 Apr; 61(4):512-519. PubMed ID: 31586002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety, Dosimetry, and Tumor Detection Ability of
    Skovgaard D; Persson M; Brandt-Larsen M; Christensen C; Madsen J; Klausen TL; Holm S; Andersen FL; Loft A; Berthelsen AK; Pappot H; Brasso K; Kroman N; Højgaard L; Kjaer A
    J Nucl Med; 2017 Mar; 58(3):379-386. PubMed ID: 27609788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hsp90 inhibition aggravates adriamycin-induced podocyte injury through intrinsic apoptosis pathway.
    Dong J; Jiang Z; Ma G
    Exp Cell Res; 2020 May; 390(2):111928. PubMed ID: 32156599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety, Tolerability and Pharmacokinetics of Icapamespib, a Selective Epichaperome Inhibitor, in Healthy Adults.
    Silverman MH; Duggan S; Bardelli G; Sadler B; Key C; Medlock M; Reynolds L; Wallner B
    J Prev Alzheimers Dis; 2022; 9(4):635-645. PubMed ID: 36281667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Companion Diagnostics to Identify Biomarkers of Response to Anticancer Drugs Targeting the Proteome.
    Joshua AM; Tannock IF
    Cancer Cell; 2019 Nov; 36(5):464-465. PubMed ID: 31715128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using
    Ulaner GA; Lyashchenko SK; Riedl C; Ruan S; Zanzonico PB; Lake D; Jhaveri K; Zeglis B; Lewis JS; O'Donoghue JA
    J Nucl Med; 2018 Jun; 59(6):900-906. PubMed ID: 29146695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1.
    Lee C; Park HK; Jeong H; Lim J; Lee AJ; Cheon KY; Kim CS; Thomas AP; Bae B; Kim ND; Kim SH; Suh PG; Ryu JH; Kang BH
    J Am Chem Soc; 2015 Apr; 137(13):4358-67. PubMed ID: 25785725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High in-vivo stability in preclinical and first-in-human experiments with [
    Qin X; Guo X; Liu T; Li L; Zhou N; Ma X; Meng X; Liu J; Zhu H; Jia B; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):302-313. PubMed ID: 36129493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiation Dosimetry and Biodistribution of
    Meyer C; Dahlbom M; Lindner T; Vauclin S; Mona C; Slavik R; Czernin J; Haberkorn U; Calais J
    J Nucl Med; 2020 Aug; 61(8):1171-1177. PubMed ID: 31836685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia.
    Sugita M; Wilkes DC; Bareja R; Eng KW; Nataraj S; Jimenez-Flores RA; Yan L; De Leon JP; Croyle JA; Kaner J; Merugu S; Sharma S; MacDonald TY; Noorzad Z; Panchal P; Pancirer D; Cheng S; Xiang JZ; Olson L; Van Besien K; Rickman DS; Mathew S; Tam W; Rubin MA; Beltran H; Sboner A; Hassane DC; Chiosis G; Elemento O; Roboz GJ; Mosquera JM; Guzman ML
    NPJ Precis Oncol; 2021 May; 5(1):44. PubMed ID: 34040147
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
    J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy.
    Bryant KG; Chae YC; Martinez RL; Gordon JC; Elokely KM; Kossenkov AV; Grant S; Childers WE; Abou-Gharbia M; Altieri DC
    Oncotarget; 2017 Dec; 8(68):112184-112198. PubMed ID: 29348817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using
    Loft M; Christensen C; Clausen MM; Carlsen EA; Hansen CP; Kroman N; Langer SW; Høgdall C; Madsen J; Gillings N; Nielsen CH; Klausen TL; Holm S; Loft A; Berthelsen AK; Kjaer A
    J Nucl Med; 2022 Dec; 63(12):1871-1879. PubMed ID: 35589407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biodistribution, Radiation Dosimetry, and Clinical Application of a Melanin-Targeted PET Probe,
    Ma X; Wang S; Wang S; Liu D; Zhao X; Chen H; Kang F; Yang W; Wang J; Cheng Z
    J Nucl Med; 2019 Jan; 60(1):16-22. PubMed ID: 29853651
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical Application of 18F-AlF-NOTA-Octreotide PET/CT in Combination With 18F-FDG PET/CT for Imaging Neuroendocrine Neoplasms.
    Long T; Yang N; Zhou M; Chen D; Li Y; Li J; Tang Y; Liu Z; Li Z; Hu S
    Clin Nucl Med; 2019 Jun; 44(6):452-458. PubMed ID: 30985413
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis of purine-scaffold fluorescent probes for heat shock protein 90 with use in flow cytometry and fluorescence microscopy.
    Taldone T; Gomes-DaGama EM; Zong H; Sen S; Alpaugh ML; Zatorska D; Alonso-Sabadell R; Guzman ML; Chiosis G
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5347-52. PubMed ID: 21802945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase I clinical study of NMB58, a novel positron emission tomography (PET)-myocardial perfusion imaging tracer, conducted to evaluate its safety and pharmacokinetics in Japanese healthy adult males.
    Kawano M; Tsuchiya J; Bae H; Kimura K; Yokoyama K; Takahashi M; Honda M; Tominaga M; Tateishi U
    Ann Nucl Med; 2021 May; 35(5):580-588. PubMed ID: 33649886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A purine analog synergizes with chloroquine (CQ) by targeting Plasmodium falciparum Hsp90 (PfHsp90).
    Shahinas D; Folefoc A; Taldone T; Chiosis G; Crandall I; Pillai DR
    PLoS One; 2013; 8(9):e75446. PubMed ID: 24098696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.